Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen.
Feldmeier JJ, Kirby JP, Buckey JC, Denham DW, Evangelista JS, Gelly HB, Harlan NP, Mirza ZK, Ray KL, Robins M, Savaser DJ, Wainwright S, Bird N, Huang ET, Moon RE, Thom SR, Weaver LK.
Feldmeier JJ, et al. Among authors: harlan np.
Undersea Hyperb Med. 2021 First Quarter;48(1):1-12. doi: 10.22462/01.03.2021.1.
Undersea Hyperb Med. 2021.
PMID: 33648028
Review.